Lim J, Hwang IC, Choi HM, Yoon YE, et al. Comparison of cardiovascular and renal outcomes between dapagliflozin and empagliflozin in patients with type 2 diabetes without prior cardiovascular or renal disease. PLoS One 2022;17:e0269414.
PMID: 36251654